← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$54K

Shares

3,847

Price

$14

Filed

Aug 12

Insider

Name

Burnett Patrick

Title

See Remarks

CIK

0001741987

Roles

Officer

Transaction Details

Transaction Date

2025-08-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

108,999

Footnotes

The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024 by the Reporting Person, with a plan end date of February 27, 2026. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.992 to $14.12, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing Info

Accession No.

0001787306-25-000126

Form Type

4

Issuer CIK

0001787306

Burnett Patrick's History

Date Ticker Type Value
2026-03-02 ARQT $154K
2026-03-02 ARQT $5K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-04 ARQT $253K
2026-02-02 ARQT $94K
2026-01-05 ARQT $72K
2025-12-31 ARQT $16K
2025-12-31 ARQT $34K
2025-12-15 ARQT M $42K

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02